R
Ramesh Nachimuthu
Researcher at VIT University
Publications - 40
Citations - 712
Ramesh Nachimuthu is an academic researcher from VIT University. The author has contributed to research in topics: Phage therapy & Biology. The author has an hindex of 10, co-authored 27 publications receiving 343 citations.
Papers
More filters
Journal ArticleDOI
Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species.
TL;DR: All the characterized phages were found to have a broad host range activity and the prepared phage cocktails were effective against mixed bacterial population that are resistant to meropenem and colistin, two last resort antibiotics.
Journal ArticleDOI
Secondary Bacterial Infections in Patients With Viral Pneumonia
Prasanth Manohar,Belinda Loh,Ramesh Nachimuthu,Xiaoting Hua,Susan C. Welburn,Sebastian Leptihn,Sebastian Leptihn +6 more
TL;DR: Clinical data of secondary bacterial infections developed after the onset of pulmonary viral infections and their treatment in SARS-CoV-2 positive patients are reviewed and treatments used or prophylactic measures employed are outlined.
Journal ArticleDOI
Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis.
Chellan Kumarasamy,Shanthi Sabarimurugan,Royam Madhav Madurantakam,Kartik Lakhotiya,Suja Samiappan,Siddhratha Baxi,Ramesh Nachimuthu,Kodiveri Muthukaliannan Gothandam,Rama Jayaraj +8 more
TL;DR: This meta-analysis protocol examines the comparative utility of neutrophil-lymphocyte-ratio, platelet-ly mphocyte- ratio, and monocyte-lyymphocyte-Ratio as a simple, inexpensive, and effective method for cancer prognosis, in multiple cancers.
Journal ArticleDOI
The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model
TL;DR: The data shows that although in vitro studies showed high infectivity of phages, for in vivo models multiple phage doses were required for effective treatment.
Journal ArticleDOI
Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?
Prasanth Manohar,Belinda Loh,Sudarsanan Athira,Ramesh Nachimuthu,Xiaoting Hua,Susan C. Welburn,Sebastian Leptihn,Sebastian Leptihn +7 more
TL;DR: In this paper, the potential of phage therapy and phage-derived therapeutic proteins and strategies in treating secondary bacterial infections, including their application in combination with chemical antibiotics, were explored.